key: cord-0903069-liewnf12
authors: Daunt, Anna; Perez‐Guzman, Pablo N.; Cafferkey, John; Manalan, Kavina; Cooke, Graham; White, Peter J.; Hauck, Katharina; Mallia, Patrick; Nayagam, Shevanthi
title: Factors associated with reattendance to emergency services following COVID‐19 hospitalization
date: 2020-10-30
journal: J Med Virol
DOI: 10.1002/jmv.26594
sha: 6c85edf07aa72a483cb6be5c8dfdf07c2b64acc6
doc_id: 903069
cord_uid: liewnf12

In May 9, 2020, a study published in this journal by Chen et al. described the symptoms and investigations of eleven patients requiring re-hospitalisation, after an index admission for COVID-19 disease. This article is protected by copyright. All rights reserved.

Factors associated with reattendance to emergency services following COVID-19 hospitalization

To the Editor, In May 9, 2020, a study published in this journal by Chen et al. 1 described the symptoms and investigations of 11 patients requiring rehospitalization, after an index admission for coronavirus disease-2019 (COVID-19). 1 Since, a limited number of reports have emerged further characterizing patients that reattend hospital services after discharged from an index COVID-19 admission. [2] [3] [4] We find contrasting evidence of reattendance rates, time to reattendance, and outcomes of such patients and that, beyond continued COVID-19 pneumonia, other indirect complications may manifest as recurrent hospital reattendances.

We analyzed reattendance data as of July 26, 2020, for a previously described cohort of patients with COVID-19 admitted between March 1 and April 5, 2020, at three large London hospitals. 5, 6 In this original cohort, 423/614 (69%) patients were discharged alive from their index COVID-19 hospitalization. As of July 26, we had followed-up these patients for a median of 112 days postdischarge (range, 2-132) and recorded that 97 (23%) reattended emergency services (Table 1) . Of these, 63 (65%) required hospitalization. The most frequent primary diagnosis at first reattendance was persisting COVID-19 pneumonia (25, 26%), followed by other infectious diseases (15, 16%; including healthcare-associated infections), cardiovascular disorders (9, 9%), and trauma (7, 7%). However, for subsequent reattendances, the most frequent primary diagnosis was other infectious diseases (20, 30%), followed by renal disorders (12, 18%) and cardiovascular disorders (6, 9%), with persisting COVID-19 symptoms in only one case (Supplement). Factors associated with reattendance were increased age (p = .01) and a higher burden of comorbidities (median Elixhauser score 5 vs. 0, p < .01; Our findings contrast with those of previous reports. Chen et al. 1 reported that their eleven patients reattended at 16 ± 7.14 days, albeit reattendance rates, how these patients were selected for inclusion, and their second admission outcomes are not discussed.

More recently, a study from New York and one from another London hospital reported a median time to reattendance of 4.5 days amongst 103 patients 2 and 10 days amongst 25 patients, 4 respectively. Reattendance rates in these studies were 3.6% and 6.4%, respectively. 2, 4 Another recent study from South Korea found that 328/ 7590 (4.3%) patients were readmitted within 3 days of discharge. 3 Importantly, in the latter study, a large portion of these patients were admitted due to recurrence of severe acute respiratory syndrome coronavirus 2 polymerase chain reaction positivity, regardless of clinical status. 3 Finally, whilst neither of the Asian studies reports reattendance outcomes, the study from New York found a death rate of 3.4% and the one from London of 24% amongst those that required rehospitalization. 2, 4 Early reattendance data may be particularly influenced by local capacity pressures and discharge practices and is not able to capture longer-term complications of COVID-19. By reviewing data over a longer period, we identified a higher proportion of patients reattending emergency services than previous reports and a wide range of secondary clinical complications. While some first reattendances in our cohort were clearly related to COVID-19, most patients presented with possible indirect complications, such as other infections and decompensation of chronic comorbidities. Of note, our cohort had a high representation of older patients with comorbidities, who might be expected to have frequent hospital attendances.

Overall, we find that reattendances following discharge from hospitalization for COVID-19 are common. Amidst the ongoing pandemic, maintaining an adequate clinical suspicion for cardiorespiratory and infectious conditions, among others, that may mimic or coexist with COVID-19 should not be undermined. 8 There is a paucity of data on the delayed complications and outcomes of these patients across different settings. Data from large, multicentre studies are urgently needed to inform a longerterm public health response to the COVID-19 pandemic and to provide an evidence base for the long-term clinical follow-up of these patients.

T A B L E 1 Factors associated with an increased probability of reattendance 

Clinical characteristics of rehospitalized patients with COVID-19 in China

Characterization of patients who return to hospital following discharge from hospitalization for COVID-19

Analysis of risk factors on readmission cases of COVID-19 in the Republic of Korea: using nationwide health claims data

COVID-19: outcomes of patients with confirmed COVID-19 re-admitted to hospital

Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study

Validity of the UK early access to medicines scheme criteria for remdesivir use in patients with COVID-19 disease

A modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data

Correct diagnosis is the key to appropriate therapy